Compare Stocks: SCNX, OPTH, PLRZ, and TXMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
OPTH Optimi Health	$3.63 -9.7%	$4.73	$3.30 ▼ $6.40	$23.02M	N/A	44,528 shs	54,161 shs
PLRZ Polyrizon	$9.05 +0.7%	$10.92	$2.88 ▼ $18.20	$21.83M	-1.2	25,738 shs	6,404 shs
SCNX Scienture	$3.91 +4.0%	$8.43	$3.23 ▼ $65.00	$6.18M	3.34	407,219 shs	37,634 shs
TXMD TherapeuticsMD	$2.02 -1.9%	$2.11	$1.03 ▼ $2.95	$23.84M	0.65	17,500 shs	14,011 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
OPTH Optimi Health	-9.70%	-15.58%	-17.87%	-11.68%	+362,999,900.00%
PLRZ Polyrizon	+0.67%	-2.27%	-17.95%	-34.23%	+34.67%
SCNX Scienture	+3.99%	+5.39%	-55.04%	-59.79%	-77.69%
TXMD TherapeuticsMD	-1.94%	+0.50%	-6.48%	+2.54%	+94.23%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
OPTH Optimi Health	$3.63 -9.7%	$4.73	$3.30 ▼ $6.40	$23.02M	N/A	44,528 shs	54,161 shs
PLRZ Polyrizon	$9.05 +0.7%	$10.92	$2.88 ▼ $18.20	$21.83M	-1.2	25,738 shs	6,404 shs
SCNX Scienture	$3.91 +4.0%	$8.43	$3.23 ▼ $65.00	$6.18M	3.34	407,219 shs	37,634 shs
TXMD TherapeuticsMD	$2.02 -1.9%	$2.11	$1.03 ▼ $2.95	$23.84M	0.65	17,500 shs	14,011 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
OPTH Optimi Health	-9.70%	-15.58%	-17.87%	-11.68%	+362,999,900.00%
PLRZ Polyrizon	+0.67%	-2.27%	-17.95%	-34.23%	+34.67%
SCNX Scienture	+3.99%	+5.39%	-55.04%	-59.79%	-77.69%
TXMD TherapeuticsMD	-1.94%	+0.50%	-6.48%	+2.54%	+94.23%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
OPTH Optimi Health	1.50	Reduce	N/A	N/A
PLRZ Polyrizon	1.00	Sell	N/A	N/A
SCNX Scienture	2.00	Hold	$37.50	859.08% Upside
TXMD TherapeuticsMD	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SCNX, OPTH, PLRZ, and TXMD Analyst Ratings

Date	Company	Brokerage	Action	Rating
10/8/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
10/2/2026	SCNX Scienture	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/21/2026	SCNX Scienture	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/18/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/1/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/27/2026	OPTH Optimi Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/26/2026	TXMD TherapeuticsMD	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D-)
8/14/2026	OPTH Optimi Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/12/2026	TXMD TherapeuticsMD	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D+)
7/29/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
OPTH Optimi Health	$310K	67.10	N/A	N/A	N/A	∞
PLRZ Polyrizon	N/A	N/A	N/A	N/A	$13.05 per share	N/A
SCNX Scienture	$430K	14.91	N/A	N/A	$43.15 per share	0.09
TXMD TherapeuticsMD	$3.02M	7.74	$0.05 per share	44.15	$2.32 per share	0.87

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
OPTH Optimi Health	-$1.12M	-$0.76	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PLRZ Polyrizon	-$3.34M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SCNX Scienture	-$41.51M	-$2.10	N/A	N/A	N/A	N/A	-53.51%	-42.47%	11/11/2026 (Estimated)
TXMD TherapeuticsMD	-$570K	$0.02	101.00	N/A	N/A	-6.64%	-1.09%	-0.78%	11/17/2026 (Estimated)

Latest SCNX, OPTH, PLRZ, and TXMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/28/2026	Q2 2026	PLRZ Polyrizon	N/A	-$0.3950	N/A	-$0.3950	N/A	N/A
8/13/2026	Q2 2026	SCNX Scienture	-$2.25	-$0.07	+$2.18	-$1.75	$1.96 million	$0.34 million
8/11/2026	Q2 2026	TXMD TherapeuticsMD	-$6.1250	$0.01	+$6.1350	$0.01	$19.77 million	$0.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
OPTH Optimi Health	N/A	N/A	N/A	N/A	N/A
PLRZ Polyrizon	N/A	N/A	N/A	N/A	N/A
SCNX Scienture	N/A	N/A	N/A	N/A	N/A
TXMD TherapeuticsMD	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
OPTH Optimi Health	0.04	0.06	0.03
PLRZ Polyrizon	N/A	36.37	N/A
SCNX Scienture	0.15	3.04	2.97
TXMD TherapeuticsMD	N/A	3.22	3.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
OPTH Optimi Health	N/A
PLRZ Polyrizon	N/A
SCNX Scienture	5.68%
TXMD TherapeuticsMD	30.74%

Insider Ownership

Company	Insider Ownership
OPTH Optimi Health	N/A
PLRZ Polyrizon	N/A
SCNX Scienture	19.51%
TXMD TherapeuticsMD	1.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
OPTH Optimi Health	9	5.73 million	N/A	N/A
PLRZ Polyrizon	1	2.43 million	N/A	N/A
SCNX Scienture	9	1.64 million	1.32 million	N/A
TXMD TherapeuticsMD	420	11.57 million	11.38 million	Optionable

SCNX, OPTH, PLRZ, and TXMD Headlines

Recent News About These Companies

Contrasting TherapeuticsMD (NASDAQ:TXMD) and GSK (NYSE:GSK)

October 10 at 3:59 AM | americanbankingnews.com

Critical Comparison: Tilray Brands (NASDAQ:TLRY) & TherapeuticsMD (NASDAQ:TXMD)

October 5, 2026 | americanbankingnews.com

TherapeuticsMD (NASDAQ:TXMD) and Shineco (NASDAQ:SISI) Head to Head Analysis

October 5, 2026 | americanbankingnews.com

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains

June 5, 2026 | marketwatch.com

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives

May 12, 2026 | tipranks.com

TherapeuticsMD Announces First Quarter 2026 Financial Results

May 12, 2026 | businesswire.com

TherapeuticsMD Inc. stock outperforms competitors on strong trading day

April 6, 2026 | marketwatch.com

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy

April 2, 2026 | theglobeandmail.com

TherapeuticsMD Explains Brief Delay In Annual Filing

April 1, 2026 | tipranks.com

TherapeuticsMD Announces Full Year 2025 Financial Results

March 30, 2026 | finance.yahoo.com

TherapeuticsMD Announces Full Year 2025 Financial Results

March 30, 2026 | businesswire.com

TherapeuticsMD (NASDAQ:TXMD) Director Tommy Thompson Buys 8,400 Shares

December 30, 2025 | insidertrades.com

TherapeuticsMD approves key proposals at annual meeting

December 16, 2025 | msn.com

TherapeuticsMD: Q3 Earnings Snapshot

November 13, 2025 | timesunion.comT

TherapeuticsMD Reports Q3 2025 Financial Results

November 13, 2025 | msn.com

TherapeuticsMD Announces Third Quarter 2025 Financial Results

November 12, 2025 | businesswire.com

TherapeuticsMD Reports Q2 2025 Financial Results

August 12, 2025 | msn.com

TherapeuticsMD: Q2 Earnings Snapshot

August 12, 2025 | finance.yahoo.com

TherapeuticsMD Announces Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors despite daily gains

July 16, 2025 | marketwatch.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SCNX, OPTH, PLRZ, and TXMD Company Descriptions

Optimi Health NASDAQ:OPTH

$3.63 -0.39 (-9.70%)

As of 10/12/2026 04:00 PM Eastern

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.

Polyrizon NASDAQ:PLRZ

$9.05 +0.06 (+0.67%)

Closing price 10/12/2026 03:59 PM Eastern

Extended Trading

$9.04 -0.02 (-0.17%)

As of 10/12/2026 07:30 PM Eastern

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Scienture NASDAQ:SCNX

$3.91 +0.15 (+3.99%)

Closing price 10/12/2026 04:00 PM Eastern

Extended Trading

$3.96 +0.05 (+1.28%)

As of 10/12/2026 07:46 PM Eastern

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

TherapeuticsMD NASDAQ:TXMD

$2.02 -0.04 (-1.94%)

As of 10/12/2026 04:00 PM Eastern

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SCNX, OPTH, PLRZ, and TXMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SCNX, OPTH, PLRZ, and TXMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SCNX, OPTH, PLRZ, and TXMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SCNX, OPTH, PLRZ, and TXMD Company Descriptions

Optimi Health NASDAQ:OPTH

Polyrizon NASDAQ:PLRZ

Scienture NASDAQ:SCNX

TherapeuticsMD NASDAQ:TXMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SCNX, OPTH, PLRZ, and TXMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SCNX, OPTH, PLRZ, and TXMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SCNX, OPTH, PLRZ, and TXMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SCNX, OPTH, PLRZ, and TXMD Company Descriptions

Optimi Health NASDAQ:OPTH

Polyrizon NASDAQ:PLRZ

Scienture NASDAQ:SCNX

TherapeuticsMD NASDAQ:TXMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools